StreetInsider.com News Articles

Form 6-K TRINITY BIOTECH PLC For: Jun 05

Fri, 05 Jun 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260605/26612023.html

Form 6-K TRINITY BIOTECH PLC For: Jun 05

Fri, 05 Jun 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260605/26612023.html

Form AW TRINITY BIOTECH PLC

Thu, 04 Jun 2026 15:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605214.html

Form AW TRINITY BIOTECH PLC

Thu, 04 Jun 2026 15:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605214.html

Form POS AM TRINITY BIOTECH PLC

Thu, 04 Jun 2026 15:12:00 -0400

si-local-file:///var/storage/secattach/20260604/26605198.html

Form POS AM TRINITY BIOTECH PLC

Thu, 04 Jun 2026 15:12:00 -0400

si-local-file:///var/storage/secattach/20260604/26605198.html

Form RW TRINITY BIOTECH PLC

Wed, 03 Jun 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260603/26600396.html

Form RW TRINITY BIOTECH PLC

Wed, 03 Jun 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260603/26600396.html

Form F-1/A TRINITY BIOTECH PLC

Wed, 03 Jun 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260603/26600386.html

Form F-1/A TRINITY BIOTECH PLC

Wed, 03 Jun 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260603/26600386.html

Form 424B3 TRINITY BIOTECH PLC

Tue, 26 May 2026 08:37:00 -0400

si-local-file:///var/storage/secattach/20260526/26546548.html

Form 424B3 TRINITY BIOTECH PLC

Tue, 26 May 2026 08:37:00 -0400

si-local-file:///var/storage/secattach/20260526/26546548.html

Form EFFECT TRINITY BIOTECH PLC

Tue, 26 May 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260526/26545256.html

Form EFFECT TRINITY BIOTECH PLC

Tue, 26 May 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260526/26545256.html

Form F-3 TRINITY BIOTECH PLC

Wed, 13 May 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260513/26486488.html

Form F-3 TRINITY BIOTECH PLC

Wed, 13 May 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260513/26486488.html

Form F-3 TRINITY BIOTECH PLC

Wed, 13 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260513/26486302.html

Form F-3 TRINITY BIOTECH PLC

Wed, 13 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260513/26486302.html

Form 6-K TRINITY BIOTECH PLC For: May 06

Wed, 06 May 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260506/26445423.html

Form 6-K TRINITY BIOTECH PLC For: May 06

Wed, 06 May 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260506/26445423.html

Form SCHEDULE 13D/A TRINITY BIOTECH PLC Filed by: PERCEPTIVE ADVISORS LLC

Mon, 04 May 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260504/26426041.html

Form SCHEDULE 13D/A TRINITY BIOTECH PLC Filed by: PERCEPTIVE ADVISORS LLC

Mon, 04 May 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260504/26426041.html

Trinity Biotech appoints Jerry Lydon to lead North America operations

Fri, 01 May 2026 09:28:36 -0400

Trinity Biotech plc (NASDAQ: TRIB) announced the appointment of Jerry Lydon as Head of North America Commercial Operations, according to a company press release. The Dublin-based diagnostics company said the appointment supports its focus on revenue quality and profitability as it completes its transformation plan.

Lydon will oversee Trinity's North America commercial organization and lead operations for the company's New York State Department of Health-approved reference laboratory. His responsibilities include supporting commercialization planning for products in development, including EpiCapture, an epigenetic assay for prostate cancer monitoring, and PrePsia, an early-pregnancy blood test for preeclampsia risk assessment.

The company reported fourth-quarter 2025 revenue

Trinity Biotech appoints Jerry Lydon to lead North America operations

Fri, 01 May 2026 09:28:36 -0400

The company reported fourth-quarter 2025 revenue

Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations

Fri, 01 May 2026 09:27:00 -0400

- Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base

- Company announces further operational progress in its Comprehensive Transformation Plan

- Company publishes Q4 2025 financial results with revenue broadly in line with previously issued trading update & year-on-year gross margin percentage improvements

DUBLIN, May 01, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB) (“Trinity” or the “Company”), a commercial‑stage diagnostics and health technology company, today announced the appointment of Jerry Lydon as Head of North America Commercial Operations.